155 related articles for article (PubMed ID: 35402303)
1. Hepatitis C Virus Infection Cycle-Specific MicroRNA Profiling Reveals Stage-Specific miR-4423-3p Targets RIG-I to Facilitate Infection.
Qian X; Wu B; Xu C; Qi Z
Front Cell Infect Microbiol; 2022; 12():851917. PubMed ID: 35402303
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.
Wang Y; Ye L; Wang X; Li J; Song L; Ho W
Innate Immun; 2013; 19(2):193-202. PubMed ID: 23060457
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
Mukherjee A; Di Bisceglie AM; Ray RB
J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
5. Dual Effects of Let-7b in the Early Stage of Hepatitis C Virus Infection.
Yeh YJ; Tseng CP; Hsu SD; Huang HY; Lai MMC; Huang HD; Cheng JC
J Virol; 2021 Jan; 95(4):. PubMed ID: 33208444
[TBL] [Abstract][Full Text] [Related]
6. Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes.
Brownell J; Wagoner J; Lovelace ES; Thirstrup D; Mohar I; Smith W; Giugliano S; Li K; Crispe IN; Rosen HR; Polyak SJ
J Hepatol; 2013 Oct; 59(4):701-8. PubMed ID: 23770038
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus reveals a novel early control in acute immune response.
Arnaud N; Dabo S; Akazawa D; Fukasawa M; Shinkai-Ouchi F; Hugon J; Wakita T; Meurs EF
PLoS Pathog; 2011 Oct; 7(10):e1002289. PubMed ID: 22022264
[TBL] [Abstract][Full Text] [Related]
8. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon-α.
Zhang X; Daucher M; Armistead D; Russell R; Kottilil S
PLoS One; 2013; 8(2):e55733. PubMed ID: 23418453
[TBL] [Abstract][Full Text] [Related]
10. High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1.
Cheng M; Si Y; Niu Y; Liu X; Li X; Zhao J; Jin Q; Yang W
J Virol; 2013 Sep; 87(17):9707-18. PubMed ID: 23824794
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway.
Duan X; Li S; Holmes JA; Tu Z; Li Y; Cai D; Liu X; Li W; Yang C; Jiao B; Schaefer EA; Fusco DN; Salloum S; Chen L; Lin W; Chung RT
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321333
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-mediated interactions between host and hepatitis C virus.
Li H; Jiang JD; Peng ZG
World J Gastroenterol; 2016 Jan; 22(4):1487-96. PubMed ID: 26819516
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor.
Liao TL; Chen YM; Hsieh SL; Tang KT; Chen DY; Yang YY; Liu HJ; Yang SS
mBio; 2021 Dec; 12(6):e0276421. PubMed ID: 34724826
[TBL] [Abstract][Full Text] [Related]
14. Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.
Thibault PA; Wilson JA
Pharmacol Res; 2013 Sep; 75():48-59. PubMed ID: 23541631
[TBL] [Abstract][Full Text] [Related]
15. HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.
Israelow B; Narbus CM; Sourisseau M; Evans MJ
Hepatology; 2014 Oct; 60(4):1170-9. PubMed ID: 24833036
[TBL] [Abstract][Full Text] [Related]
16. Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity.
Herzog K; Bandiera S; Pernot S; Fauvelle C; Jühling F; Weiss A; Bull A; Durand SC; Chane-Woon-Ming B; Pfeffer S; Mercey M; Lerat H; Meunier JC; Raffelsberger W; Brino L; Baumert TF; Zeisel MB
Gut; 2020 Feb; 69(2):380-392. PubMed ID: 31076402
[TBL] [Abstract][Full Text] [Related]
17. Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers.
Peng X; Li Y; Walters KA; Rosenzweig ER; Lederer SL; Aicher LD; Proll S; Katze MG
BMC Genomics; 2009 Aug; 10():373. PubMed ID: 19671175
[TBL] [Abstract][Full Text] [Related]
18. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
[TBL] [Abstract][Full Text] [Related]
19. Depletion of MicroRNA-373 Represses the Replication of Hepatitis C Virus via Activation of Type 1 Interferon Response by Targeting IRF5.
Gong W; Guo X; Zhang Y
Yonsei Med J; 2018 Dec; 59(10):1181-1189. PubMed ID: 30450852
[TBL] [Abstract][Full Text] [Related]
20. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
